Eton Pharmaceuticals, Inc (ETON) released Loss for fourth quarter of -$0.60 million
The company's earnings totaled -$0.60 million, or -$0.02 per share. This compares with -$2.26 million, or -$0.09 per share, last year.
The company's revenue for the period rose 59.4% to $11.65 million from $7.31 million last year.
Eton Pharmaceuticals, Inc earnings at a glance (GAAP) :
-Earnings: -$0.60 Mln. vs. -$2.26 Mln. last year.
-EPS: -$0.02 vs. -$0.09 last year.
-Revenue: $11.65 Mln vs. $7.31 Mln last year.
For comments and feedback: editorial@rttnews.com